Title: The Innovations of Stefan Toegel
Introduction
Stefan Toegel is an inventive mind based in Tullnerbach, Austria. He is currently associated with AOP Orphan Pharmaceuticals AG, where he contributes to the field of pharmaceutical innovations. Although he has not yet been granted any patents, his work is focused on developing novel compositions that enhance drug bioavailability.
Latest Patent Applications
One of Stefan Toegel's notable patent applications is titled "Fast Disintegrating Compositions Comprising Nabilone and Randomly Methylated Beta Cyclodextrin." This invention presents a unique composition that includes Nabilone and randomly methylated B-cyclodextrin (RAMEB). The application specifies that the weight ratio between Nabilone and RAMEB is approximately 1:60-1:140. Furthermore, the invention outlines methods aimed at increasing the bioavailability of Nabilone, which could have significant implications for its therapeutic use.
Conclusion
Stefan Toegel's contributions to pharmaceutical innovations, particularly through his latest patent application, highlight his commitment to enhancing drug formulations. His work has the potential to impact the effectiveness of treatments in the medical field.